[1]. Sung H et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021 Feb 4.[2]. Freudenberg J A, Wang Q, Katsumata M, et al. The role of HER2 in early breast cancer metastasis and the ori...
参考文献：[1]. WHO. International Angency for Research on Cancer, Cancer today: https://gco.iarc.fr/today/home. (2020). Accessed 27 Jan 2022.[2]. Gonzalez-Angulo AM, et al. High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive...
1. Sung H et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021 Feb 4. 2. Freudenberg J A, Wang Q, Katsumata M, et al....
参考文献: [1] Oh DY, Bang YJ. HER2-targeted therapies - a role beyond breast cancer. Nat Rev Clin Oncol. 2020 Jan;17(1):33-48. doi: 10.1038/s41571-019-0268-3. Epub 2019 Sep 23. PMID: 31548601.
HER2-Low Breast Cancer: Pathological and Clinical Landscape. J Clin Oncol. 2020;38(17):1951-1962. doi:10.1200/JCO.19.02488 3.Ting Zhang, Lingfeng You, Jianyan Xu, Junzhao Yin, Bolei Qu, Yuchang Mao, Beibei Fu, Dan Cao, Linda Zhao, Jun Feng, Min Hu, Feng He; Abstract LB031: ...
[1]OhDY,BangYJ.HER2-targetedtherapies-arolebeyondbreastcancer.NatRevClinOncol.2020Jan;17(1):33-48.doi:10.1038/s41571-019-0268-3.Epub2019Sep23.PMID:31548601. 责任编辑:木棉 声明:本文系药智网转载内容,图片、文字版权归原作者所有,转载目的在于传递更多信息,并不代表本平台观点。如涉及作品内容、版权和...
4. Hurvitz SA, et al. Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: Updated results of the randomized, phase 3 study DESTINY-Breast03. 2022 SABCS. GS2-02. 5. https://www.cde.org.cn/ ...
[1] Krishnamurti U, Silverman JF. HER2 in breast cancer: a review and update. Adv Anat Pathol. 2014 Mar;21(2):100-7 [2] Connell CM, Doherty GJ. Activating HER2 mutations as emerging targets in multiple solid cancers. ESMO Open. 2017 Nov 24;2(5):e000279...
[2]. Gonzalez-Angulo AM, et al. High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller. J Clin Oncol 2009; 27: 5700-6. [3]. Onitilo AA, et al. Breast cancer subtypes based on ER/PR...
https://gco.iarc.fr/today/home. (2020) [2]. Tarantino P, et al. HER2-Low Breast Cancer: Pathological and Clinical Landscape. J Clin Oncol. 2020 Jun 10;38(17):1951-1962. [3]. 羟乙磺酸达尔西利片说明书.国家食品药品监督管理总局药品审评中心. 2021年12月31日....